SCHEMBL6581277

SCHEMBL6581277

C=CCn1nc(-c2ccc(OC)cc2)nc1-c1cccc(C=O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.43
NR1H3 Q13133 1/20 0.43
KDM4E B2RXH2 5/20 0.42
GFER P55789 1/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
ALDH1A1 P00352 3/20 0.42
HPGD P15428 3/20 0.42
TSHR P16473 3/20 0.42
TP53 P04637 3/20 0.42
HSD17B10 Q99714 3/20 0.42
MAPT P10636 2/20 0.42
HTT P42858 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
RAB9A P51151 4/20 0.40
NPC1 O15118 3/20 0.40
TDP1 Q9NUW8 1/20 0.40
GAA P10253 1/20 0.40
AVPR1B P47901 7/20 0.40
TGM2 P21980 1/20 0.39
TGM1 P22735 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6584100 0.96 NR1H2 (0.48) NR1H2NR1H3KDM4EGFERSMN1; SMN2
SCHEMBL6580805 0.88 TGM2 (0.51) NR1H2NR1H3KDM4ESMN1; SMN2ALDH1A1
SCHEMBL6581299 0.87 NR1H2 (0.45) NR1H2NR1H3KDM4ESMN1; SMN2ALDH1A1
SCHEMBL6581102 0.86 NR1H3 (0.57) NR1H2NR1H3SMN1; SMN2ALDH1A1MAPT
SCHEMBL6580838 0.85 TSHR (0.44) NR1H2NR1H3ALDH1A1HPGDTSHR
SCHEMBL6582921 0.85 NR1H3 (0.43) NR1H2NR1H3KDM4ESMN1; SMN2ALDH1A1
SCHEMBL6580979 0.85 NR1H2 (0.43) NR1H2NR1H3TSHRRAB9ANPC1
SCHEMBL6581365 0.85 NR1H3 (0.43) NR1H2NR1H3TSHRRAB9ANPC1
SCHEMBL6578401 0.84 NR1H2 (0.43) NR1H2NR1H3KDM4ESMN1; SMN2ALDH1A1
SCHEMBL6578727 0.84 NR1H2 (0.43) NR1H2NR1H3TSHRRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1070708-B1 Triazole derivatives HOFFMANN LA ROCHE (CH) 2004-01-14 EP disclosed
US-6265426-B1 CENTRAL NERVOUS SYSTEM DISORDERS HOFFMANN-LA ROCHE INC. 2001-07-24 US disclosed
EP-1070708-A1 Triazole and imidazole derivatives F. HOFFMANN-LA ROCHE AG (CH) 2001-01-24 EP disclosed